Literature DB >> 19802870

Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells.

Beatrice C Milon1, Anthony Agyapong, Roderick Bautista, Leslie C Costello, Renty B Franklin.   

Abstract

BACKGROUND: Normal prostate accumulates extremely high levels of zinc compared to other soft tissues. In contrast, the level of zinc in the prostate decreases significantly in prostate cancer. We have shown that down-regulation of the expression of the zinc transporter hZIP1 in prostate cancer is an important event that is responsible for the decrease of zinc levels. However, the mechanism of hZIP1 down-regulation is not known. We have hypothesized that hZIP1 is down-regulated through transcriptional regulation.
METHODS: The hZIP1 promoter was studied using luciferase reporter assays, site-directed mutagenesis, gel shift, and ChIP assay.
RESULTS: We have characterized a promoter region, downstream of the transcription start site, responsible for repression of hZIP1 transcription. We demonstrate that this region contains a binding site for the Ras-Responsive Element Binding protein 1 (RREB-1) and that the binding of RREB-1 to the hZIP1 promoter is involved in the decrease of hZIP1 transcription in PC-3 cells.
CONCLUSION: The Ras pathway and activation of RREB-1 are involved in hZIP1 down-regulation and may play a role in the decrease of the transporter expression in prostate cancer. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19802870      PMCID: PMC4041352          DOI: 10.1002/pros.21063

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  23 in total

1.  The human ZIP1 transporter mediates zinc uptake in human K562 erythroleukemia cells.

Authors:  L A Gaither; D J Eide
Journal:  J Biol Chem       Date:  2001-04-11       Impact factor: 5.157

2.  Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer.

Authors:  V Y Zaichick; T V Sviridova; S V Zaichick
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  Terminal oxidation and the effects of zinc in prostate versus liver mitochondria.

Authors:  Leslie C Costello; Zhixin Guan; Boone Kukoyi; Pei Feng; Renty B Franklin
Journal:  Mitochondrion       Date:  2004-08       Impact factor: 4.160

Review 4.  Signal transduction in prostate cancer progression.

Authors:  Daniel Gioeli
Journal:  Clin Sci (Lond)       Date:  2005-04       Impact factor: 6.124

5.  ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells.

Authors:  Jonathan Clarhaut; Robert M Gemmill; Vincent A Potiron; Slimane Ait-Si-Ali; Jean Imbert; Harry A Drabkin; Joëlle Roche
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

Review 6.  Ras signaling in prostate cancer progression.

Authors:  Michael J Weber; Daniel Gioeli
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

7.  RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas.

Authors:  A Thiagalingam; A De Bustros; M Borges; R Jasti; D Compton; L Diamond; M Mabry; D W Ball; S B Baylin; B D Nelkin
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells.

Authors:  R B Franklin; J Ma; J Zou; Z Guan; B I Kukoyi; P Feng; L C Costello
Journal:  J Inorg Biochem       Date:  2003-08-01       Impact factor: 4.155

9.  Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate.

Authors:  L C Costello; R B Franklin
Journal:  Enzyme       Date:  1981

10.  15-LOX-1 transcription suppression through the NuRD complex in colon cancer cells.

Authors:  X Zuo; J S Morris; R Broaddus; I Shureiqi
Journal:  Oncogene       Date:  2009-02-09       Impact factor: 9.867

View more
  19 in total

1.  The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.

Authors:  Jason A Bonomo; Meijian Guan; Maggie C Y Ng; Nicholette D Palmer; Pamela J Hicks; Jacob M Keaton; Janice P Lea; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

2.  Evidence for changes in RREB-1, ZIP3, and Zinc in the early development of pancreatic adenocarcinoma.

Authors:  Leslie C Costello; Jing Zou; Mohamed Mokhtar Desouki; Renty B Franklin
Journal:  J Gastrointest Cancer       Date:  2012-12

3.  Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.

Authors:  Peter B Makhov; Konstantin V Golovine; Alexander Kutikov; Daniel J Canter; Vera A Rybko; Dmitry A Roshchin; Vsevolod B Matveev; Robert G Uzzo; Vladimir M Kolenko
Journal:  Carcinogenesis       Date:  2011-09-22       Impact factor: 4.944

Review 4.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Arch Biochem Biophys       Date:  2016-04-27       Impact factor: 4.013

5.  Resveratrol-zinc combination for prostate cancer management.

Authors:  Chandra K Singh; Anna Pitschmann; Nihal Ahmad
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

6.  RREB1 transcription factor splice variants in urologic cancer.

Authors:  Matthew D Nitz; Michael A Harding; Steven C Smith; Shibu Thomas; Dan Theodorescu
Journal:  Am J Pathol       Date:  2011-07       Impact factor: 4.307

7.  hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).

Authors:  Jing Zou; Beatrice C Milon; Mohamed M Desouki; Leslie C Costello; Renty B Franklin
Journal:  Prostate       Date:  2011-02-25       Impact factor: 4.104

Review 8.  Zinc and zinc transporters in prostate carcinogenesis.

Authors:  Vladimir Kolenko; Ervin Teper; Alexander Kutikov; Robert Uzzo
Journal:  Nat Rev Urol       Date:  2013-03-12       Impact factor: 14.432

9.  A Review of the Current Status and Concept of the Emerging Implications of Zinc and Zinc Transporters in the Development of Pancreatic Cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Pancreat Disord Ther       Date:  2013

10.  The cytotoxic role of RREB1, ZIP3 zinc transporter, and zinc in human pancreatic adenocarcinoma.

Authors:  Renty B Franklin; Jing Zou; Leslie C Costello
Journal:  Cancer Biol Ther       Date:  2014-07-22       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.